Shanghai Junshi Biosciences Co., Ltd.

HK$15.69As of Sun 8 Nov 2026, 12:00 UTC
HKEX:1877Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 8Y CAGR (5.37%)
Div yield —
ROE (9.02%)
Biotechnology
Beta (5Y) 0.63
PE TTM —
TSR TTM (40.97%)
Mkt cap HK$31.81B
ROIC (1.81%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$15
(3.77%)
(11.59%)
Buy 8|1|1|6|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.26
0.25
0.26
0.28
18.43%
6.50%
5.38%
12.60%
Revenue¥B
1.810
1.887
2.001
1.991
6.72%
8.97%
16.94%
12.49%
Peers (US$4.058B)
Cap (US$)
PE
4.470B
9.667x
3.756B
35.19x
Capital
TTM
5Y
10Y
Leveragex
0.330
0.496
0.478
EBIT/Intx
17.06
0.281
0.280
Own earn%
(57.51)
138.03
120.56
Sh yield%
34.05
18.04
17.14
Owners
Insiders/Inst%
10.02
30.36
Short interest%
2.96
SBC / revenue%
4.84
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
28–31
$1 testx
—
Incr. ROIC%
1